Gabriella Cusano
ScholarGPS® ID: 65201004273258
Affiliation History
Field
Medicine
Discipline
Pediatrics
Top Specialties
Cancer
Metrics Summary
Publication Count
9
Predicted Citations
100
Predicted h-index
6
Ranking
Publications and Citation History
Publications based on Top Specialties
Types of Publication
- Publications
- Books
- Patents
- NIH/NSF
Add
Delete
|
---|
hTERT Transduction Extends the Lifespan of Primary Pediatric Low-Grade Glioma Cells While Preserving the Biological Response to NGF (journal article) Pathology and Oncology Research, volume 27 (2021). |
Toxicology in Vitro, volume 29, issue 7, pages 1628-1638 (2015). |
Preclinical evaluation of the novel 7-substituted camptothecin Namitecan (ST1968) in paediatric tumour models (journal article) Cancer Chemotherapy and Pharmacology, volume 70, issue 6, pages 811-822 (2012). |
Enhanced cell cycle perturbation and apoptosis mediate the synergistic effects of ST1926 and ATRA in neuroblastoma preclinical models (journal article) Investigational New Drugs, volume 30, issue 4, pages 1319-1330 (2012). |
Antitumor activity and pharmacokinetics of oral gimatecan on pediatric cancer xenografts (journal article) Cancer Chemotherapy and Pharmacology, volume 66, issue 4, pages 635-641 (2010). |
Antitumor effect in medulloblastoma cells by gefitinib: Ectopic HER2 overexpression enhances gefitinib effects in vivo (journal article) Neuro-Oncology, volume 11, issue 3, pages 250-259 (2009). |
Antitumor activity of imatinib mesylate in medulloblastoma cell lines and xenografts (journal article) Journal of Clinical Oncology, volume 22, issue 14_suppl, pages 8554-8554 (2004). |
The cellular response to PPARgamma ligands is related to the phenotype of neuroblastoma cell lines. (journal article) Oncology research, volume 14, issue 7-8 (2004). |
The Cellular Response to PPARγ Ligands Is Related to the Phenotype of Neuroblastoma Cell Lines (journal article) Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, volume 14, issue 7, pages 345-354 (2004). |